{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:45:43Z","timestamp":1775612743357,"version":"3.50.1"},"reference-count":27,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Candida species are a common cause of invasive infection in neonates and children. The aim of our study was to evaluate the epidemiology and microbiology of invasive candidiasis (IC) in the largest tertiary Greek pediatric hospital during a 10-year period. A retrospective cohort study was performed from January 2008 to December 2017. Identification of species and antifungal susceptibility testing was performed according to the Clinical and Laboratory Standards Institute (CLSI) methodology. During the study period, 178 cases of IC were recorded. The tissue distribution included blood (87.1%), cerebrospinal (7.9%), peritoneal (3.9%) and pleural fluids (1.1%). Candida albicans and Candida parapsilosis (sensu lato) were the most frequently isolated species (47.8% and 28.7% respectively). From period 2008\u20132012 to period 2013\u20132017, a significant decrease in IC rates was detected (0.21 cases\/1000 hospitalization days VS 0.11 cases\/1000 hospitalization days, P = 0.040), while median minimum inhibitory concentrations (MICs) of amphotericin B were significantly increased for both C. albicans and C. parapsilosis (sl) (P = 0.037 and P = 0.004 respectively). The decrease in IC rates may reflect the increased awareness as well as the effective infection control initiatives and antifungal interventions. However, the significant increase in the MICs for amphotericin B and echinocandins such as caspofungin, raises concerns about their common use as first-line treatment. Epidemiologic monitoring is, therefore, critically important in order to evaluate and optimize therapeutic protocols for IC in pediatric populations.<\/jats:p>","DOI":"10.3390\/jof5010019","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T11:26:14Z","timestamp":1550834774000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period"],"prefix":"10.3390","volume":"5","author":[{"given":"Maria","family":"Noni","sequence":"first","affiliation":[{"name":"First Department of Pediatrics, Division of Infectious Diseases, \u201cAghia Sophia\u201d Children\u2019s Hospital, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Stathi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, \u201cAghia Sophia\u201d Children\u2019s Hospital, 115 27 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Vaki","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, Division of Infectious Diseases, \u201cAghia Sophia\u201d Children\u2019s Hospital, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristea","family":"Velegraki","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levantia","family":"Zachariadou","sequence":"additional","affiliation":[{"name":"Department of Microbiology, \u201cAghia Sophia\u201d Children\u2019s Hospital, 115 27 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1745-1118","authenticated-orcid":false,"given":"Athanasios","family":"Michos","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, Division of Infectious Diseases, \u201cAghia Sophia\u201d Children\u2019s Hospital, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: A persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1185\/03007995.2010.487796","article-title":"Candidemia in children","volume":"26","author":"Zaoutis","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Prevention and management of invasive infections in neonates and children caused by Candida spp.","volume":"18","author":"Hope","year":"2012","journal-title":"Clin. Microbial. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus","volume":"42","author":"Pfaller","year":"2004","journal-title":"J. Clin. Microbial."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin. Microbial. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1093\/jpids\/piy009","article-title":"Neonatal and Pediatric Candidemia: Results from Population-Based Active Laboratory Surveillance in Four US Locations, 2009\u20132015","volume":"7","author":"Benedict","year":"2018","journal-title":"J. Pediatric Infec. Dis. Soc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)","volume":"49","author":"Pfaller","year":"2011","journal-title":"J. Clin. Microbial."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2012). M27\u2013S4: Reference method for broth dilution antifungal susceptibility testing of yeasts, fourth information supplement, Clinical and Laboratory Standards Institute (CLSI)."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/myc.12570","article-title":"Candida infections in paediatrics: Results from a prospective single-centre study in a tertiary care children\u2019s hospital","volume":"60","author":"Mesini","year":"2017","journal-title":"Mycoses"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JCM.06346-11","article-title":"Declining incidence of candidemia in a tertiary inpatient pediatric population","volume":"50","author":"Ota","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/cid\/cit679","article-title":"Decreasing rates of invasive candidiasis in pediatric hospitals across the United States","volume":"58","author":"Fisher","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1111\/j.1469-0691.2011.03720.x","article-title":"Candidaemia in a European Paediatric University Hospital: A 10-year observational study","volume":"18","author":"Tragiannidis","year":"2012","journal-title":"Clin. Microbial. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mantadakis, E., Pana, Z.D., and Zaoutis, T. (2018). Candidemia in children: Epidemiology, prevention and management. Mycoses.","DOI":"10.1111\/myc.12792"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5152\/TurkPediatriArs.2017.5291","article-title":"Evaluation of Candida species and antifungal susceptibilities among children with invasive candidiasis","volume":"52","author":"Sutcu","year":"2017","journal-title":"Turk. Pediatri. Arsivi."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00134-013-3057-y","article-title":"Invasive candidiasis in pediatric intensive care in Greece: A nationwide study","volume":"39","author":"Vogiatzi","year":"2013","journal-title":"Intens. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1345\/aph.1Q346","article-title":"Echinocandin use in the neonatal intensive care unit","volume":"46","author":"Caudle","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/JCM.40.3.852-856.2002","article-title":"Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000","volume":"40","author":"Pfaller","year":"2002","journal-title":"J. Clin. Microbial."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist. Update."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/AAC.00355-12","article-title":"Caspofungin Etest susceptibility testing of Candida species: Risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints","volume":"56","author":"Arendrup","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2006.08.047","article-title":"Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults","volume":"29","author":"Gualco","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s11046-017-0155-3","article-title":"Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years","volume":"182","author":"Piccinelli","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/JCM.43.6.2729-2735.2005","article-title":"Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit","volume":"43","author":"Sarvikivi","year":"2005","journal-title":"J. Clin. Microbial."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and reporting of candidaemia in Belgium: A multi-centre study","volume":"36","author":"Trouve","year":"2017","journal-title":"Eur. J. Clin. Microbial. Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/1\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:34:05Z","timestamp":1760186045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/1\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["jof5010019"],"URL":"https:\/\/doi.org\/10.3390\/jof5010019","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]}}}